Patent & IP news for July 27, 2016

USPTO Weekly Stats


Patent & IP Blogs

Taylor Swift assists recording artists, Apple Music, and (even) herself from

Taylor Swift, a pop star with sufficient power to move mountains, succeeded last year in moving an equally resolute object: Apple Music’s position on paying royalties to recording artists.  A year later it is ...

Share via E–mail | Twitter | Facebook

Google Anti-Piracy Report Criticized by Content Owners from

Google is doing more to counter online copyright infringement than ever before, it said in its “How Google Fights Piracy 2016 Update,” claiming takedowns of over 500 million webpages in response to rights holder requests ...

Share via E–mail | Twitter | Facebook

WTO DG Sees Positive Changes, More Engagement; Would Consider A Second Term from

World Trade Organization Director General Roberto Azevêdo today said he would consider a second mandate at the head of the organisation. He also described a positive momentum in the organisation in the first semester of ...

Share via E–mail | Twitter | Facebook

South African Government Staves Off Critics With IP Consultative Framework from

South Africa’s Department of Trade and Industry (DTI) appears to be meeting its detractors halfway with a new intellectual property consultative framework it says will help pave the way for consultative engagement with IP ...

Share via E–mail | Twitter | Facebook

Network Information Management Patent Invalid Under 35 U.S.C. § 101 from

The court granted defendants' motion to dismiss because the asserted claims of plaintiff’s network information management patent encompassed unpatentable subject matter and found that the claims were directed toward an abstract idea. "Plaintiff responds ...

Share via E–mail | Twitter | Facebook

Illumina v. Ariosa: the CAFC discusses the phrase “relating to” from

The outcome of Illumina v. Ariosa

Illumina, Inc. (“Illumina”) appeals a district court order
denying Illumina’s motion to compel arbitration.
Illumina and Ariosa Diagnostics, Inc. (“Ariosa”) entered
into a supply agreement in which the ...

Share via E–mail | Twitter | Facebook

Many Hepatitis C Patients Do Not Have Access To Medicines In India, Group Says from

Despite being the global leader of generic drug manufacturing, access to hepatitis C treatment in India remains out of reach for a large portion of the population, a civil society group has said in a ...

Share via E–mail | Twitter | Facebook

This is Why You Have an Editor: Politics, Plagiarism, and Copyright from

The inescapable world of U.S. politics, especially in an election year, consistently offers much legal debate. Somewhat less often, politicians and their entourages accidentally wade into the domain of intellectual property law. Politicians have ...

Share via E–mail | Twitter | Facebook

US Senate Judiciary Chairman Questions High Cost Of Medicare Drug Coverage from

United States Senate Judiciary Committee Chairman Charles Grassley, an Iowa Republican, has demanded answers from the government Medicare programme regarding the rapid rise in costs of coverage of Americans’ prescription drugs. The demand follows a ...

Share via E–mail | Twitter | Facebook

Libraries, Groups Welcome WIPO Copyright Appointment, With Hope from

A range of highly active groups at the World Intellectual Property Organization representing libraries, archives, and digital civil liberties this week welcomed the appointment of a copyright industry lobbyist to lead WIPO copyright issues. But ...

Share via E–mail | Twitter | Facebook

They Invented What? (No. 8) from

Originally posted on Anticipate This!™ | Patent and Trademark Law Blog:
U.S. Pat. No. 6,982,161:  Process for the utilization of ruminant animal methane emissions.   I claim:  1. A method for producing methane-utilizing microorganisms ...

Share via E–mail | Twitter | Facebook

Genzyme Therapeutic Products Ltd. v. Biomarin Pharmaceutical Inc. (Fed. Cir. 2016) from

By Kevin E. Noonan -- The Federal Circuit affirmed the decision by the Patent Trial and Appeals Board (PTAB) in an inter partes review (IPR) that the claims of Genzyme's U.S Patent Nos. 7 ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2016 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact